EZH2 and breast carcinoma: Studies have shown that simultaneous induction of miR-101 and treatment with Syn-cal14.1a, a synthetic peptide acquired from Californiconus californicus, suppresses EZH2-induced breast cancer cell migration, invasion, and proliferation and promotes apoptosis of BC cells [116].